- Report
- October 2024
- 186 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2025
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 359 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 184 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- March 2025
- 227 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 141 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- September 2023
- 200 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2024
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1188EUR$1,250USD£998GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1188EUR$1,250USD£998GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- December 2023
- 199 Pages
Global
From €3421EUR$3,599USD£2,874GBP
- Report
- August 2024
- 108 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- April 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- November 2021
- 656 Pages
Global
From €4753EUR$5,000USD£3,993GBP

G Protein Coupled Receptors (GPCRs) are a class of proteins that are involved in a wide range of physiological processes, including cell signaling, metabolism, and homeostasis. They are the most abundant type of membrane receptor in the human body, and are involved in the regulation of many cellular processes. GPCRs are the target of many drugs, and are the focus of much research in the field of proteomics.
Proteomics is the study of the structure and function of proteins, and GPCRs are a major focus of proteomics research. Proteomics research has enabled the development of new drugs and therapies that target GPCRs, and has also enabled the development of new diagnostic tools for diseases that involve GPCRs.
Companies in the GPCR market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more